Aktiesnakken — September 2010
-
ja runski det er noget man kan som plus
-
at vi har bygget en chat istedet for bare at køre EI - stilen gør at vi mister et massivt antal sidevisninger, og vi er altså ikke nået
-
breakeven endnu. Og udvikling koster penge.....
-
det er som Johnsen skriver ligesom alt andet her i livet.....
-
Nordea Markets har ansat analytikeren Michael Novod
som
pharma-analytiker. -
er Hatholt smuttet?
-
det må han jo så være? synes heller ikke han dækkede Genmab pludseligt?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
